Announcement
European Journal of Drug Metabolism and Pharmacokinetics invites submission of Original Research, Practical Application, Current Opinion and Review Articles on the topics of preclinical and clinical pharmacokinetics and pharmacodynamics.
Submit Now!

European Journal of Drug Metabolism and Pharmacokinetics promotes drug development by providing researchers essential information on preclinical and clinical pharmacokinetics & pharmacodynamics, including drug disposition, metabolism, transport and interactions, therapeutic drug monitoring, pharmacokinetic/pharmacodynamic relationship, bioavailability and biopharmacy.

As a hybrid journal, European Journal of Drug Metabolism and Pharmacokinetics does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require. This is achieved via the Springer Open Choice™ initiative. More information about this optional route to open access and the associated article processing charge can be found by clicking on the ‘Learn about publishing Open Access with us’ link below.

European Journal of Drug Metabolism and Pharmacokinetics offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

Journal information

Editor-in-Chief
  • Jasbir Singh
Publishing model
Hybrid. Learn about publishing Open Access with us

Journal metrics

2.441 (2020)
Impact factor
2.202 (2020)
Five year impact factor
28 days
Submission to first decision
100 days
Submission to acceptance
84,233 (2020)
Downloads

Latest articles

This journal has 85 open access articles

Journal updates

  • Digital Features

    European Journal of Drug Metabolism and Pharmacokinetics is able to host a range of digital features, with a number of options available to authors.

    Digital Features
View all updates

About this journal

Electronic ISSN
2107-0180
Print ISSN
0378-7966
Abstracted and indexed in
  1. BFI List
  2. BIOSIS
  3. Biological Abstracts
  4. CAB Abstracts
  5. CNKI
  6. Chemical Abstracts Service (CAS)
  7. Dimensions
  8. EBSCO Discovery Service
  9. EMBASE
  10. Google Scholar
  11. Japanese Science and Technology Agency (JST)
  12. Journal Citation Reports/Science Edition
  13. Medline
  14. Meta
  15. Naver
  16. OCLC WorldCat Discovery Service
  17. Pathway Studio
  18. ProQuest-ExLibris Primo
  19. ProQuest-ExLibris Summon
  20. Reaxys
  21. SCImago
  22. SCOPUS
  23. Science Citation Index Expanded (SciSearch)
  24. TD Net Discovery Service
  25. UGC-CARE List (India)
Copyright information

Rights and permissions

Springer policies

© Springer Nature Switzerland AG